Expert panel discussion: The best of iwCLL 2015
Listen now
Description
Prof John Gribben (University London and Barts, London, UK) chairs a discussion for ecancertv at iwCLL 2015 with Prof Michael Hallek (University Clinic of Cologne, Cologne, Germany) Dr Michael Keating (University of Texas MD Anderson Cancer Center, Houston, USA) Prof Kanti Rai (Long Island Jewish Medical Center, New York, USA) about the highlights of iwCLL 2015. They focus on the current and evolving landscape of CLL and potential treatment pathways. They also note the importance of the integration of the Young Investigators Meeting (YIM) within the main iwCLL congress.
More Episodes
Published 08/11/17
Dr O’Brien talks to ecancertv at the 2015 International Workshop on Chronic Lymphocytic Leukaemia (CLL) about the results of a new phase I study of duvelisib (IPI-145) in patients with relapsed or refractory CLL.
Published 08/11/17
Professor Catovsky speaks to ecancertv at the 2015 International Workshop on Chronic Lymphocytic Leukaemia (CLL) about the long-term outcomes of the fludarabine plus cyclophosphamide in a randomised controlled trial for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial).
Published 08/11/17